Skip Navigation
Search Menu
The Sidney Kimmel Comprehensive Cancer Center

In This Section      
Print This Page

Prevention, Diagnosis, and Treatment

Image of smiling man, Jerry Morton, with black Baltimore Ravens football t-shirt. Jerry Morton, retired firefighter, is battling his lung cancer with an epigenetic therapy as part of Johns Hopkins-based research and an ongoing clinical trial.

More than 221,000 people will be diagnosed with lung cancer in the United States each year. Slightly more than 158,000 people will die, more than from colon, breast, and prostate cancers combined.

These sobering statistics motivate the team devoted to lung cancer at Johns Hopkins in their efforts to offer those at risk for lung cancer tools and knowledge to prevent the disease and to offer those patients diagnosed with lung cancer expert treatment and groundbreaking clinical trials.

A multidisciplinary approach

Because lung cancer requires a multi-modality (more than one treatment) approach, the lung cancer team at Johns Hopkins operates as a multidisciplinary unit that includes medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, nurse practitioners, and others. These specialists participate in Johns Hopkins’ multidisciplinary clinic, which offers patients and their families the opportunity to meet with the specialists to discuss the diagnosis and create a treatment plan.

Groundbreaking research

For every member of the team, the goal is to offer patients the best prognosis possible. That’s why practitioners at Johns Hopkins often do research as well. Researchers can offer the latest experimental treatments to patients. Working across disciplines opens up new possibilities for better ways to treat lung cancer. Lung cancer patients at Johns Hopkins receive not only experienced, specialized care but also benefit from the pioneering lung cancer research that has resulted in new treatments and therapies.

With the pioneering research in epigenetics, signal transduction, immunotherapy, and biomarkers taking place at Johns Hopkins, the promise of longer life is closer than ever to becoming a reality.

Find out more